UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000013882 |
|---|---|
| Receipt number | R000016196 |
| Scientific Title | A Randomized, phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first-line induction therapy for extensive disease small-cell lung cancer HOT1401/NJCLG1401 |
| Date of disclosure of the study information | 2014/06/10 |
| Last modified on | 2019/05/07 11:35:38 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/05/03 18:09:34 | ||
| 2 | Update | 2014/11/04 08:53:36 | Recruitment status |
|
| 3 | Update | 2019/05/07 11:35:38 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
